ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 316 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2021. The put-call ratio across all filers is 0.51 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $537,400 | -24.6% | 20,000 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $713,200 | +47.8% | 20,000 | +5.3% | 0.00% | 0.0% |
Q1 2023 | $482,600 | -37.4% | 19,000 | 0.0% | 0.00% | -33.3% |
Q4 2022 | $770,640 | +22.7% | 19,000 | 0.0% | 0.00% | +50.0% |
Q3 2022 | $628,000 | -6.1% | 19,000 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $669,000 | -23.5% | 19,000 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $874,000 | -30.6% | 19,000 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $1,260,000 | +6.2% | 19,000 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $1,186,000 | -24.7% | 19,000 | 0.0% | 0.00% | -33.3% |
Q2 2021 | $1,574,000 | -5.1% | 19,000 | -24.0% | 0.00% | 0.0% |
Q1 2021 | $1,658,000 | -13.6% | 25,000 | 0.0% | 0.00% | -25.0% |
Q4 2020 | $1,918,000 | +78.3% | 25,000 | 0.0% | 0.00% | +100.0% |
Q3 2020 | $1,076,000 | -0.4% | 25,000 | 0.0% | 0.00% | -33.3% |
Q2 2020 | $1,080,000 | +134.8% | 25,000 | +56.2% | 0.00% | +50.0% |
Q1 2020 | $460,000 | -54.7% | 16,000 | 0.0% | 0.00% | -33.3% |
Q4 2019 | $1,015,000 | – | 16,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 908,474 | $24,410,696 | 22.12% |
Western Financial Corp/CA | 820,239 | $22,039,822 | 16.16% |
JOHNSON & JOHNSON | 247,598 | $6,652,958 | 2.45% |
WEALTH EFFECTS LLC | 164,750 | $4,426,835 | 2.19% |
M28 Capital Management LP | 67,400 | $1,811,038 | 2.08% |
Privium Fund Management B.V. | 259,036 | $6,960,298 | 2.07% |
Evolutionary Tree Capital Management, LLC | 51,266 | $1,377,517 | 1.78% |
Avidity Partners Management LP | 1,063,897 | $28,586,912 | 1.15% |
SECTORAL ASSET MANAGEMENT INC | 157,552 | $4,233,422 | 0.82% |
Vivo Capital, LLC | 137,411 | $3,692,234 | 0.40% |